We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » 2022 Funding Bill Advances Out of Committee With $3.45 Billion for FDA — and Added Requests
2022 Funding Bill Advances Out of Committee With $3.45 Billion for FDA — and Added Requests
The House Committee on Appropriations has advanced legislation to increase nonuser-fee funding to the FDA by $257 million to $3.45 billion in fiscal year 2022 and the fast-moving bill is on its way to the House floor with a vote expected in July — but there may be a few catches.